NVS
The table below shows Novartis AG's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $25.55B | $25.23B | $29.52B | $29.11B | $29.77B | $29.10B |
| Total assets | $104.39B | $97.50B | $110.98B | $122.91B | $124.02B | $123.76B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | - | - | - | - | - | - |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $62.34B | $55.60B | $59.05B | $59.90B | $69.89B | $69.88B |
| Retained earnings | - | - | - | - | - | - |
| Total equity | - | - | - | - | - | - |